ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,048.42
      -0.46%
      US Tech 100
      17,162.80
      0.60%
      Dow Jones
      38,085.80
      -0.98%
      Brent Oil
      88.16
      0.01%
      Bitcoin
      64,225.84
      -0.40%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Hoth Therapeutics Inc (HOTH)

      7. Hoth Therapeutics Inc (HOTH) News

      HOTH Hoth Therapeutics Inc

      1.17
      0.00 (0.00%)
      Apr 25 2024 - Closed
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Hoth Therapeutics Inc HOTH NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.00 0.00% 1.17 20:00:00
      Open Price Low Price High Price Close Price Prev Close
      1.14 1.10 1.20 1.17 1.17
      more quote information »

      Recent News

      Date Time Source Heading
      4/25/20248:52IHNWFeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
      3/27/202414:00PRNUSHoth Therapeutics Announces Exercise of Warrants for $4.2..
      3/27/202408:27PRNUSHoth Therapeutics' Wholly Owned Subsidiary Merveille.ai,..
      3/19/202408:21PRNUSHoth Therapeutics Announces Positive Data In Completed Study..
      2/29/202408:38PRNUSHoth Therapeutics Retains Venable LLP to Expand Its Patent..
      2/26/202408:11PRNUSHoth Therapeutics Engages Altasciences to Perform Key Study..
      2/13/202411:45PRNUSHoth Therapeutics to Attend BIO CEO and Investor Conference,..
      1/18/202408:20PRNUSHoth Therapeutics Announces it Received FDA Approval to..
      1/09/202415:03EDGAR2Form 8-K - Current report
      1/08/202417:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/08/202417:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/08/202417:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/08/202417:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/27/202308:21PRNUSHoth Therapeutics Announces Expansion of FDA Cleared..
      12/05/202308:33PRNUSHoth Therapeutics Announces it Has Successfully Completed..
      11/14/202308:37PRNUSHoth Therapeutics Announces Successful Completion of Pre-IND..
      11/13/202316:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      11/10/202308:00PRNUSHoth Therapeutics to Present at NobleCon's 19th Annual..
      10/05/202310:03PRNUSHoth Therapeutics Announces Merveille.ai Artificial..
      10/05/202308:15EDGAR2Form 8-K - Current report
      10/02/202308:33PRNUSFDA Grants Hoth Therapeutics Pre-IND Meeting for HT-KIT,..
      9/15/202316:15EDGAR2Form 8-K - Current report
      9/15/202314:38PRNUSHoth Therapeutics Announces Closing of $2.89 Million..
      9/14/202317:24EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
      9/13/202313:43PRNUSHoth Therapeutics Announces $2.89 Million Registered Direct..
      9/13/202308:16PRNUSHoth Therapeutics Announces Positive Results Killing Cancer..
      9/11/202310:04PRNUSHoth Therapeutics Announces FDA Accepts Pre-Investigational..
      9/06/202308:12PRNUSHoth Therapeutics Announces Positive Final Results from..
      8/21/202317:10EDGAR2Form 8-K - Current report
      8/21/202317:00EDGAR2Form S-8 - Securities to be offered to employees in employee..
      8/11/202316:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      8/09/202308:13PRNUSHoth Therapeutics Announces Positive Preclinical End Point..
      7/25/202308:12PRNUSHoth Therapeutics Announces Major Milestone of First Patient..
      7/19/202308:02PRNUSHoth Therapeutics Receives Protocol Approval for HT-001..
      7/18/202316:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      7/18/202316:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      7/18/202316:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      7/18/202316:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      6/14/202308:12PRNUSHoth Therapeutics Announces IRB Approval for FDA Cleared..
      6/06/202308:02PRNUSHoth Therapeutics Announces Positive Preclinical Results of..
      5/12/202308:38PRNUSHoth Therapeutics and Algorithm Sciences Terminate Letter of..

      Your Recent History

      NASDAQ
      HOTH
      Hoth Therapeutics
      Delayed Upgrade Clock